Target intelligence / Profile preview

Inversin (INVS)

Target
INVS
Molecular classification
ciliary protein, ankyrin-repeat protein
01

Overview

Inversin (INVS) is a ciliary protein with multiple ankyrin-repeat domains and IQ calmodulin-binding domains[2][4]. It is essential for normal renal development, particularly the development and maintenance of renal tubules, and plays a central role in the establishment of left-right asymmetry during embryonic development[2][3][4]. Inversin is considered the molecular switch between the canonical and non-canonical Wnt signaling pathways, inhibiting canonical Wnt signaling by targeting Dishevelled (DVL1) for proteasomal degradation[3][4]. This regulatory role underlies its importance in terminal differentiation of renal tubular epithelial cells and correct tissue organization[4]. INVS is a core component of the “inversin compartment” of the primary cilium, where it functions with ANKS6, NEK8, and NPHP3[1]. It also interacts with several proteins, including calmodulin, nephrocystin (NPHP1), Dishevelled (DVL), Akt, and beta-catenin[2][3]. Mutations in INVS cause nephronophthisis type 2, an autosomal recessive childhood-onset cystic kidney disease[2][4]. INVS is not classified as a typical therapeutic target (such as a receptor, enzyme, transporter, or ion channel), and no approved drugs are known to act directly on this protein.

Other names
INVNPHP2NPH2inversion of embryo turning homolognephrocystin-2nephrocystin 2inversin
02

Biological functions

Renal tubular development and functionEstablishment of left-right body axis in embryogenesisRegulation of primary cilia functionRegulation of Wnt signaling (acts as a molecular switch between canonical and non-canonical pathways)Cell cycle regulation (alignment of spindle axis during cell division)
03

Disease associations

Nephronophthisis type 2 (childhood-onset cystic kidney disease, NPHP2 or infantile nephronophthisis)Other ciliopathies (less established, through general role in cilia)

Beyond the preview

Go deeper on Inversin (INVS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inversin (INVS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call